Publications by authors named "Peter Buehlmayer"

5Publications

An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation.

Authors:
Daniela Angst Philipp Janser Jean Quancard Peter Buehlmayer Frederic Berst Lukas Oberer Christian Beerli Markus Streiff Charles Pally Rene Hersperger Christian Bruns Frederic Bassilana Birgit Bollbuck

J Med Chem 2012 Nov 26;55(22):9722-34. Epub 2012 Oct 26.

Novartis Pharma AG, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
November 2012

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis.

Authors:
Jean Quancard Birgit Bollbuck Philipp Janser Daniela Angst Frédéric Berst Peter Buehlmayer Markus Streiff Christian Beerli Volker Brinkmann Danilo Guerini Paul A Smith Timothy J Seabrook Martin Traebert Klaus Seuwen René Hersperger Christian Bruns Frédéric Bassilana Marc Bigaud

Chem Biol 2012 Sep;19(9):1142-51

Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland.

View Article and Find Full Text PDF
September 2012

New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck.

Authors:
Nina Gommermann Peter Buehlmayer Anette von Matt Werner Breitenstein Keiichi Masuya Bernard Pirard Pascal Furet Sandra W Cowan-Jacob Gisbert Weckbecker

Bioorg Med Chem Lett 2010 Jun 29;20(12):3628-31. Epub 2010 Apr 29.

Novartis Institute of Biomedical Research, Forum 1, Novartis Campus, Basel, Switzerland.

View Article and Find Full Text PDF
June 2010

Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists.

Authors:
Heinrich Rueeger Marc Gerspacher Peter Buehlmayer Pascal Rigollier Yasuchika Yamaguchi Tibur Schmidlin Steven Whitebread Barbara Nuesslein-Hildesheim Hanspeter Nick Leoluca Cricione

Bioorg Med Chem Lett 2004 May;14(10):2451-7

Novartis Pharma AG, Novartis Institutes for BioMedical Research Basel, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
May 2004

Development of tridentate iron chelators: from desferrithiocin to ICL670.

Authors:
Hanspeter Nick Pierre Acklin René Lattmann Peter Buehlmayer Suzanne Hauffe Joachim Schupp Daniele Alberti

Curr Med Chem 2003 Jun;10(12):1065-76

Novartis Pharma Ltd., Basel, Switzerland.

View Article and Find Full Text PDF
June 2003